LCP-Tacro tacrolimus: Phase II data

In an open-label, U.S. Phase II study in 46 evaluable stable kidney transplant patients, once-daily LCP-Tacro showed better pharmacokinetics vs. twice-daily Prograf. The immunosuppressant improved bi...